Scientific Advisory Board

Rita Colwell, Ph.D.

Rita Colwell, Ph.D.

Co-Chair

  • Internationally recognized scientist, microbiologist and founder of CosmosID, a privately held bioinformatics firm
  • Distinguished University Professor at U. Maryland and Johns Hopkins University
  • Former Director, National Science Foundation (1998 – 2006)
  • National Medal of Science awardee
  • Member, US National Academy of Sciences
Sharon H. Hrynkow, PhD

Sharon H. Hrynkow, PhD

Co-Chair

Chief Scientific Officer, Senior Vice President of Medical Affairs, Cyclo Therapeutics

  • Neuroscientist with more than 25 years’ experience in global health arena, public and private sectors
  • Senior executive at NIH
  • First president of non-profit Global Virus Network
  • Former Member of President’s Council of Advisors on Science and Technology
Caroline Hastings, M.D.

Caroline Hastings, M.D.

Key Opinion Leader in Niemann-Pick Disease Type C

  • Pediatric hematologist oncologist, Director of Neuro-oncology, and Professor of Pediatrics, UCSF Benioff Children’s Hospital Oakland
  • First physician in US to use cyclodextrins for treatment in NPC, compassionate use
  • Advisor to US and Australian NPC Advocacy organizations and to physicians globally on NPC
Gerald F. Cox, MD, PhD

Gerald F. Cox, MD, PhD

Key Opinion Leader in Niemann-Pick Disease Type C

  • Over 15 years in senior leadership at Sanofi Genzyme, including Vice President of Rare Disease Clinical Development
  • Led the clinical development of CRISPR-based genome editing medicines to treat human diseases, including the first approved IND for a CRISPR-based medicine to be delivered in vivo that is designed to treat a genetic form of blindness called Leber congenital amaurosis type 10.
  • Affiliated with Boston Children’s Hospital during his entire career, where he is a part-time Staff Physician in Genetics; and is an Instructor in Pediatrics at Harvard Medical School.
Benny Liu, M.D.

Benny Liu, M.D.

Key Opinion Leader in Niemann-Pick Disease Type C

  • Gastroenterologist at Alameda Healthy System, CA and Highland Hospital
  • Globally recognized expert in lipid metabolism
  • First to discover that cyclodextrins release cholesterol from cells using an animal model
  • Assistant Clinical Professor, UCSF

Trappsol® Cyclo™ is not currently approved for any indication.

Third-party websites are provided for convenience only. Cyclo Therapeutics, Inc. does not approve of, or endorse any of the content. Cyclo Therapeutics, Inc. does not maintain, control or monitor the content of third-party websites in any way.